login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock News
Canada
- TSX-V:SVA -
CA81752F1062
-
Common Stock
0.185
CAD
0 (0%)
Last: 9/11/2025, 7:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SVA.CA Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Sernova Corp.
Sernova Announces First Two Patients Implanted with Cell Pouch™ in the Second Cohort of its US Phase 1/2 Clinical Trial for Type 1 Diabetes
3 years ago - By: Sernova Corp.
Sernova to Participate in the Stifel Healthcare Conference
3 years ago - By: Sernova Corp.
Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes
3 years ago - By: Sernova Corp.
Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference
3 years ago - By: Sernova Corp.
Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022
3 years ago - By: Sernova Corp.
Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium
3 years ago - By: Sernova Corp.
Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors
3 years ago - By: Sernova Corp.
Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share
3 years ago - By: Sernova Corp.
Sernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.
3 years ago - By: Sernova Corp.
Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June
3 years ago - By: Sernova Corp.
Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022
3 years ago - By: Sernova Corp.
Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes
5 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Resumption - SVA
5 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Halt - SVA
5 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Resumption - SVA
5 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Halt - SVA
Please enable JavaScript to continue using this application.